Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.
Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
- Does not allow reviews to be publicly displayed
- Only allows reviewers to display the journal they reviewed for
Interested in reviewing for this journal?
Your interest in reviewing is shared with journals or conferences when they are partnered with us. Learn more.
Editorial board members on Publons
Publons users have indicated that they sit on Drugs' editorial board but we are unable to verify these claims. If you are an administrator for Drugs, please get in touch to find out how you can verify the contributions of your editorial board members and more.
Top reviewers on Publons (Manuscripts reviewed in last 12 months)
No one has yet endorsed Drugs.
Review contents for Drugs are not publicly displayed on Publons, in accordance with their editorial policy.